Antiresorptive Effect of Treatment With Risedronate and Vitamin D in Postmenopausal Patients
Conditions: Postmenopausal Osteoporosis; Hypovitaminosis D; Hyperparathyroidism Interventions: Drug: Risedronate; Drug: Vitamin D Sponsors: Hospital Regional 1o de Octubre; National Polytechnic Institute, Mexico; Universidad Nacional Autonoma de Mexico Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Actonel | Hyperparathyroidism | Mexico Health | Orthopaedics | Osteoporosis | Research | Risedronate | Vitamin D | Vitamins